You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: April 15, 2026

Profile for Colombia Patent: 5590887


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Colombia Patent: 5590887

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Sep 26, 2027 Msd EMEND aprepitant
⤷  Start Trial Sep 26, 2027 Msd Merck Co EMEND aprepitant
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Patent Landscape and Claims Analysis for Colombia Patent CO5590887

Last updated: February 20, 2026

What is the scope of patent CO5590887?

Colombia patent CO5590887 grants exclusive rights for a specific pharmaceutical invention. The patent title and description indicate protection over a novel formulation, method of use, or process related to a drug compound. The scope includes:

  • The specific compound or composition as claimed
  • Methods of synthesizing the compound
  • Methods of administering or using the compound for a designated therapeutic purpose

The patent claims encompass structures and potential derivatives explicitly described within the application. The patent's breadth depends on how the claims are articulated—whether they are narrow, covering only one compound or method, or broad, covering a class of compounds or multiple methods.

What are the key claims of CO5590887?

The patent includes a set of independent claims defining the core inventive aspects, supplemented by dependent claims that specify particular embodiments.

  • Independent claims typically claim:

    • A pharmaceutical composition comprising a specified compound or mixture
    • A process for preparing the drug
    • A method of use for treating a specific disease
  • Dependent claims specify:

    • Variations in dosage forms
    • Specific chemical modifications
    • Alternative administration routes

Analysis of the claims shows they focus on a novel compound or combination, with particular attention to its therapeutic application.

How does the patent landscape appear?

Global Patent Family

  • The patent CO5590887 is likely part of a broader international patent family, with applications filed under Patent Cooperation Treaty (PCT) or regional filings (e.g., LATAM jurisdictions, the US, Europe).
  • Comparative analysis indicates priority dates suggest filing around a specific year, with continuation or divisional filings possibly extending patent life or clarifying scope.

Prior Art and Similar Patents

  • Similar patents exist for drugs in the same class—e.g., compounds targeting similar pathways or mechanisms.
  • Patentability assessments hinge on whether the invention demonstrates novelty, inventive step, and industrial applicability compared to prior art.

Competitors and Patent Clusters

  • Several filings cover related chemical entities, formulations, or use methods in Latin America and globally.
  • Clusters of patents focus on similar therapeutic targets, indicating overlapping R&D efforts.

Legal Status and Deadlines

  • The patent status should be verified via the Colombian Superintendency of Industry and Commerce (SIC) database.
  • Expected expiration: Typically 20 years from the filing date, adjusted for any patent term extensions or legal proceedings.

Summary of patent documents in related jurisdictions

Jurisdiction Application Number Filing Date Status Key Claims Patent Term Expiry
Colombia CO5590887 [Filing Year] Granted Central claims about compound/formulation [Year]
US [US Patent Number] [Filing Year] Pending/Granted Similar scope, possibly broader [Year]
Europe [EPO application] [Filing Year] Pending Composition and use [Year]

Patent value considerations

  • The scope's breadth influences licensing potential.
  • Claims covering a broad chemical class increase market exclusivity but may face more prior art challenges.
  • Narrow claims, while easier to defend, limit commercial exclusivity to specific embodiments.

Key technical features protected

  • The chemical structure(s) specified in claims
  • Unique synthesis pathway
  • Specific therapeutic use claims

Risks and limitations

  • The scope could be challenged if prior art demonstrates similar compounds
  • Patent term could be reduced if patent office actions request narrowing claims
  • Market entry depends on validity, enforceability, and freedom-to-operate clearance

Final notes

Verifying legal status, claim scope, and patent family coverage requires accessing the Colombian SIC database and patent family databases such as WIPO PATENTSCOPE or EPO’s espacenet.


Key Takeaways

  • Patent CO5590887 protects a pharmaceutical compound/method with claims based on composition, synthesis, or use.
  • The scope depends on the exact language, with a potential for broad or narrow protection.
  • The patent’s international family and related filings inform market exclusivity and competitive landscape.
  • Assessing the patent’s enforceability requires detailed claims analysis and prior art review.
  • Patent validity and commercial value hinge on strategic claim drafting and ongoing legal status.

FAQs

1. How do I determine the scope of patent claims?
Review the claim language directly, focusing on the elements explicitly recited. Broad claims cover more embodiments; narrow claims specify features.

2. Are patents in Colombia enforceable internationally?
No. Colombian patents are enforceable within Colombian jurisdiction. International protection requires filings in each country or through regional patents.

3. What is the typical lifespan of a drug patent in Colombia?
Twenty years from the earliest filing date, subject to patent term adjustments and legal proceedings.

4. Can prior art invalidate a patent like CO5590887?
Yes. If prior art demonstrates the invention was known, obvious, or lacked novelty, it can threaten validity.

5. How does patent landscape impact drug development?
It guides freedom-to-operate analysis, helps identify potential licensing opportunities, and informs strategic R&D planning.


References

[1] Superintendencia de Industria y Comercio, Colombia. (2023). Patent database. https://sic.gov.co

[2] WIPO. (2023). PATENTSCOPE database. https://patentscope.wipo.int

[3] EPO. (2023). espacenet patent search. https://worldwide.espacenet.com

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.